comprehensive -WSS

comprehensive

author：focus 2025-09-06 03:26:11 - browse：9983

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： DeSantis talks Trump, trans issues and 'what wokeness is'

explore

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Driven by the pandemic, applicants flood public health schools

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Affordable Connectivity Program vital to health care, experts say

Affordable Connectivity Program vital to health care, experts say

hotspot

comprehensive

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Peter Hotez and the public health issue of online harassment

I learned firsthand about improving diversity in clinical trials

As demand for Covid shots wanes, Moderna seeks its next success

Awakening the world to the whoosh: A patient's crusade

Affirmative action in medical school literally saved lives

Leukemia patients are helped by Syndax's new type of therapy

Apple is now the first public company to be valued at $3 trillion

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Anesthesiologist group: stop taking Ozempic before surgery

DeSantis talks Trump, trans issues and 'what wokeness is'

Wikipedia

Winning ticket for $1 billion Powerball jackpot sold in California

Indian pharmaceutical industry in denial over drug

Vir antibody drug aimed at influenza A fails in clinical trial

Stanford president's case begs question: Who takes blame?

Pharma patents targeted by Biden in move to slash drug prices

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

leisure time

hotspot

explore

Wikipedia